Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


CHMP recommends Velsipity (etrasimod) for the treatment of ulcerative colitis – Pfizer

Written by | 21 Dec 2023

On 14 December 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product… read more.

FDA approves Omvoh (mirikizumab-mrkz), a first-in-class treatment for adults with moderately to severely active ulcerative colitis – Eli Lilly

Written by | 1 Nov 2023

Eli Lilly and Company announced that the FDA has approved Omvoh (mirikizumab-mrkz) infusion (300 mg/15 mL)/injection (100 mg/mL), the first and only interleukin-23p19 (IL-23p19) antagonist for the treatment… read more.

Frequent use of antibiotics may heighten inflammatory bowel disease risk in over 40s

Written by | 11 Jan 2023

Frequent use of antibiotics may heighten the risk of inflammatory bowel disease—Crohn’s disease and ulcerative colitis—among the over 40s, suggests research published online in the journal Gut. The risk… read more.

Maintaining healthy lifestyle might prevent up to 60% of inflammatory bowel disease cases

Written by | 11 Dec 2022

Adopting and maintaining a healthy lifestyle might prevent up to 60% of inflammatory bowel disease cases—Crohn’s disease and ulcerative colitis—finds a large international study, published online in the… read more.

Adverse pregnancy outcomes in women with inactive inflammatory bowel disease

Written by | 10 Nov 2022

Inflammatory bowel disease is a risk factor for giving birth preterm even when in apparent disease remission, a University of Gothenburg study shows. If corroborated, the results may… read more.

Inflammatory bowel disease increases risks for pregnant women

Written by | 8 Aug 2022

Pregnant women with inflammatory bowel disease (IBD) and their babies face increased risks and complications compared to pregnant women without IBD. Those are the findings from a new… read more.

Antibiotic use associated with inflammatory bowel disease in older adults

Written by | 16 May 2022

The more antibiotics prescribed to patients 60 and older, the more likely they were to develop inflammatory bowel disease, suggesting antibiotic use could explain some of the growth… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.